Molecular epidemiology of neisseria meningitidis serogroup B in Brazil

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  de Filippis, Ivano ^a,b,c   de Lemos, Ana Paula S ^d   Hostetler, Jessica B ^e,g   Wollenberg, Kurt ^c   Sacchi, Claudio T ^d   Harrison, Lee H ^f   Bash, Margaret C ^b   Prevots, D Rebecca ^c  

^a Oswaldo Cruz Foundation   (Brazil)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d INSTITUTO ADOLFO LUTZ   (Brazil)

^e J CRAIG VENTER INSTITUTE   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OUTER MEMBRANE PROTEIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BRAZIL; CELL LINEAGE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; IMMUNOGENICITY; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SPECIES DIVERSITY; UNINDEXED SEQUENCE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BIODIVERSITY; CLASSIFICATION; GENETICS; GEOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; MENINGOCOCCOSIS; MICROBIOLOGY; MOLECULAR GENETICS; PHYLOGENY; STATISTICAL MODEL; TIME;

NEISSERIA MENINGITIDIS SEROGROUP B;

BACTERIAL TYPING TECHNIQUES; BASE SEQUENCE; BIODIVERSITY; BRAZIL; GENES, BACTERIAL; GENETIC VARIATION; GEOGRAPHY; HUMANS; LIKELIHOOD FUNCTIONS; MENINGOCOCCAL INFECTIONS; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS, SEROGROUP B; PHYLOGENY; TIME FACTORS;

EID: 84858201930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033016     Document Type: Article

References (41)

1. Sacchi CT, Pessoa LL, Ramos SR, Milagres LC, Camargo MCC, et al. (1992) Ongoing group B Neisseria meningitidis epidemic in São Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex. Journal of Clinical Microbiology 30: 1734-8.
2. de Lemos AP, Yara TY, Gorla MC, Paiva MV, de Souza AL, et al. (2007) Clonal distribution of invasive Neisseria meningitidis serogroup C strains circulating from 1976 to 2005 in greater São Paulo, Brazil. Journal of Clinical Microbiology 45: 1266-73.
3. Holst J, Martin D, Arnold R, Huergo CC, Oster P, et al. (2009) Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 27 (Suppl 2): B3-12.
4. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arica B, et al. (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287: 1816-20.
5. Fletcher LD, Bernfield L, Barniak V, Farley JE, Howell A, et al. (2004) Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infection and Immunity 72: 2088-100.
6. Giuliani MM, Adu-Bobie J, Comanducci M, Arico B, Savino B, et al. (2006) A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci 103: 10834-9.
7. Cordeiro SM, Neves AB, Ribeiro CT, Petersen ML, Gouveia EL, et al. (2007) Hospital-based surveillance of meningococcal meningitis in Salvador, Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 101: 1147-53.
8. Baethgen LF, Weidlich L, Moraes C, Klein C, Nunes LS, et al. (2008) Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing. Tropical Medicine & International Health 13: 31-40.
9. de Filippis I, Vicente AC, (2005) Multilocus sequence typing and repetitive element-based polymerase chain reaction analysis of Neisseria meningitides isolates in Brazil reveal the emergence of 11 new sequence types genetically related to the ST-32 and ST-41/44 complexes and high prevalence of strains related to hypervirulent lineages. Diagn Microbiol Infect Dis 53: 161-7.
10. Sacchi CT, Lemos AP, Popovic T, de Moraes JC, Whitney AM, et al. (2001) Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997-1998: overview and implications for vaccine development. Journal of clinical microbiology 39: 2897-903.
11. Comanducci M, Bambini S, Brunelli B, Adu-Babie J, Arico B, et al. (2002) NadA, a novel vaccine candidate of Neisseria meningitidis. J Exp Med 195: 1445-54.
12. Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Babie J, et al. (2003) Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. The Journal of Experimental Medicine 197: 789-99.
13. Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, et al. (2006) The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177: 501-10.
14. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proceedings of the National Academy of Sciences of the United States of America 95: 3140-5.
15. Suker J, Feavers IM, Achtman M, Morelli G, Wang JF, et al. (1994) The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Molecular microbiology 12: 253-65.
16. Urwin R, Kaczmarski EB, Guiver M, Fox AJ, Maiden MM, (1998) Amplification of the meningococcal porB gene for non-culture serotype characterization. Epidemiology and infection 120: 257-62.
17. Thompson EA, Feavers IM, Maiden MC, (2003) Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology 149: 1849-58.
18. Sutton GG, Adams MD, Kervlage AR, (1995) A new tool for assembling large sequencing projects. Genome Science and Technology 1: 9-19.
19. Thompson JD, Gibson TJ, Higgins DG, (2002) Multiple sequence alignment using ClustalW and ClustalX. Current protocols in bioinformatics Chapter 2: 1-22.
20. Hall T, (1999) Bioedit: a user friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41: 95-98.
21. Jolley KA, Maiden MC, (2010) BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC bioinformatics 11: 595.
22. Edgar RC, (2004) MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC bioinformatics 5: 113.
23. Didelot X, Falush D, (2007) Inference of bacterial microevolution using multilocus sequence data. Genetics 175: 1251-1266.
24. Garli website. Available: http://garli.googlecode.com. Accessed 2011 Jul 13.
25. Swofford D, (2003) Phylogenetic analysis using parsimony (and other methods) Sunderland, MA Sinauer Associates.
26. Comanducci M, Bambini S, Caugant DA, Mora M, Brunelli B, et al. (2004) NadA diversity and carriage in Neisseria meningitidis. Infection and immunity 72: 4217-2.
27. Jolley KA, Brehoney C, Maiden MC, (2007) Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol 31: 89-96.
28. Barroso DE, Carvalho DM, Casagrande ST, Rebelo MC, Soares V, et al. (2010) Microbiological epidemiological history of meningococcal disease in Rio de Janeiro, Brazil. The Brazilian Journal of Infectious Diseases 14: 242-51.
29. Sacchi CT, Lemos AP, Brandt ME, Whitney AM, Melles CEA, et al. (1998) Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system. Clinical and diagnostic laboratory immunology 5: 348-54.
30. Website for the Brazilian Institute of Geography and Statistics (IBGE). Available: http://www.ibge.gov.br/ibgeteen/mapas/imagens/demografia_gde.gif. Accessed 2011 Aug 25.
31. Russell JE, Urwin R, Gray SJ, Fox AJ, Feavers IM, et al. (2008) Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines. Microbiology 154: 1170-7.
32. Urwin R, Russell JE, Thompson EA, Holmes EC, Feavers IM, et al. (2004) Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infection and immunity 72: 5955-62.
33. Findlow J, Borrow R, Snape MD, Dawson T, Holland A, et al. (2010) Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clinical Infectious Diseases 51: 1127-37.
34. Jiang HQ, Hoiseth SK, Harris SL, McNeil LK, Zhu D, et al. (2010) Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. Vaccine 28: 6086-93.
35. Keiser PB, Biggs-Cicatelli S, Moran EE, Schmeil DH, Pinto VB, et al. (2011) A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression. Vaccine 29: 1413-20.
36. Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, et al. (2010) Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine. Clinical and Vaccine Immunology 17: 919-29.
37. Bambini S, Muzzi A, Olcen P, Rappuoli R, Pizza M, et al. (2009) Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus. Vaccine 27: 2794-803.
38. Murphy E, Andrew L, Lee KL, Ditts DA, Nunuez L, et al. (2009) Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. The Journal of infectious diseases 200: 379-89.
39. Wang X, Cohn A, Comanducci M, Andrew L, Zhao X, et al. (2009) Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States. Vaccine 29: 4739-4734.
40. Pajon R, Beernink PT, Harrison LH, Granoff DM, (2010) Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates. Vaccine 28: 2122-9.
41. Brehony C, Jolley KA, Maiden MC, (2007) Multilocus sequence typing for global surveillance of meningococcal disease. FEMS microbiology reviews 31: 15-26.